We have a suspicion that you are an automated web bot software, not a real user. To keep our site fast for other users, we have slowed down this page. The slowdown will gradually disappear. If you think this is a mistake, please contact us at genome-www@soe.ucsc.edu. Also note that all data for hgGeneGraph can be obtained through our public MySQL server and all our software source code is available and can be installed locally onto your own computer. If you are unsure how to use these resources, do not hesitate to contact us.
UCSC Genome Browser Gene Interaction Graph
Gene interactions and pathways from curated databases and text-mining

◀ Back to MAPK10

MAPK10 — MITF

Text-mined interactions from Literome

Ahn et al., Arch Dermatol Res 2008 (MAP Kinase Signaling System) : Furthermore, p38 MAPK functionally regulated the LPS induced melanin formation in melanocytes ; a p38 MAPK inhibitor, SB203580, almost completely attenuated the LPS mediated up-regulation of melanin synthesis and induction of MITF and tyrosinase expression
Jiang et al., Life Sci 2009 (Melanoma, Experimental) : Furthermore, Western blot analysis revealed that THSG elevated the level of phosphorylation of p38 mitogen activated protein kinase ( p38 MAPK ) significantly at 1-6 h ; a p38 MAPK inhibitor, SB203580, almost completely attenuated the THSG mediated up-regulation of melanin synthesis and induction of MITF and tyrosinase expression
Park et al., International journal of cell biology 2009 : Then the activated MAPK/ERK caused an acute phosphorylation of MITF , followed by proteosome mediated degradation of MITF, the key transcription factor for melanogenic proteins [ Wu et al. ( 2000 ) Gene & Development : 14 ]
Wu et al., J Biomed Sci 2011 (Hyperpigmentation...) : Cpc exerted dual antimelanogenic mechanisms by upregulation of MAPK/ERK dependent degradation of MITF and downregulation of p38 MAPK regulated CREB activation to modulate melanin formation
Zhou et al., J Ethnopharmacol 2012 (Melanoma, Experimental) : The special p38 MAPK inhibitor, SB203580, and protein kinase A (PKA) inhibitor, H89, both attenuated the AVE induced up-regulation of MITF and tyrosinase expression in B16F10 cells and NHMC ... AVE exerts its improving effect on melanogenesis mainly by p38 MAPK activation and MITF induction of tyrosinase